CABALETTA BIO INC (CABA) — insider trading
Health Care · NASDAQ
CABALETTA BIO INC (CABA) has 12 reported SEC Form 4 insider transactions in our data, including 1 open-market purchase among the most recent 12 (latest 2026-06-09).
Recent Form 4 transactions
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026-06-09 | Brun Scott C. | Director | Grant / award / vesting (derivative) | 22,000 | $0.00 | $0 | Form 4 |
| 2026-06-09 | Bollard Catherine | Director | Grant / award / vesting (derivative) | 22,000 | $0.00 | $0 | Form 4 |
| 2026-06-09 | HENRIQUES RICHARD C JR | Director | Grant / award / vesting (derivative) | 22,000 | $0.00 | $0 | Form 4 |
| 2026-06-09 | Simon Mark | Director | Grant / award / vesting (derivative) | 22,000 | $0.00 | $0 | Form 4 |
| 2026-06-09 | Tomasello Shawn | Director | Grant / award / vesting (derivative) | 22,000 | $0.00 | $0 | Form 4 |
| 2026-03-02 | Marda Anup | Officer (Chief Financial Officer) | Grant / award / vesting (derivative) | 225,000 | $0.00 | $0 | Form 4 |
| 2026-03-02 | Nichtberger Steven | Director, Officer (President & CEO) | Grant / award / vesting (derivative) | 674,000 | $0.00 | $0 | Form 4 |
| 2026-03-02 | Chang David J. | Officer (Chief Medical Officer) | Grant / award / vesting (derivative) | 225,000 | $0.00 | $0 | Form 4 |
| 2026-03-02 | Binder Gwendolyn | Officer (President, Science & Tech.) | Grant / award / vesting (derivative) | 225,000 | $0.00 | $0 | Form 4 |
| 2026-03-02 | Gerard Michael | Officer (General Counsel) | Grant / award / vesting (derivative) | 175,000 | $0.00 | $0 | Form 4 |
| 2026-03-02 | Das Arun | Officer (Chief Business Officer) | Grant / award / vesting (derivative) | 175,000 | $0.00 | $0 | Form 4 |
| 2026-01-21 | Chang David J. | Officer (Chief Medical Officer) | Open-market purchase | 8,800 | $2.26 | $19.9K | Form 4 |
Ask the chat about CABA's insider activity →
Transaction types are the SEC Form 4 codes: open-market purchases (P) and sales (S) are the only rows that reflect open-market conviction. Awards/vesting (A), option exercises (M/X/C), shares withheld for taxes (F) and gifts (G) are compensation or mechanical, not buying or selling on the open market. Sales may be planned and non-discretionary (e.g. a Rule 10b5-1 plan); open-market buying is not a recommendation to buy. Informational only — not financial advice.
Source: SEC EDGAR Form 3/4/5. See the full company profile: CABALETTA BIO INC (CABA).
Last updated 2026-06-09 (most recent filing date).
Informational only — NOT financial advice. Insider filings are sourced from SEC EDGAR and shown with their reported dates.